- A device called the ExAblate Neuro from closely held Israeli company InSightec, whose owners include GE (NYSE:GE), was able to bring significant improvements to sufferers of essential tremor in a small trial of 15 people.
- The device works by shooting over 1,000 ultrasound beams deep into the brain to stop the the aberrant electrical signals that cause the tremors.
- ExAblate Neuro represents the first non-invasive treatment for essential tremors, a close relative of Parkinson's Disease that effects 10M people in the U.S.
- Existing treatments include the implanting of deep-brain stimulation devices from companies such as Medtronic (NYSE:MDT).